Ordeniza, Juncris P.
HRN: 20-79-98 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/12/2022
04/19/2022
IV
30MG
Q12
PCAP-C UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes